Calendar Cyclacel Pharmaceuticals, Inc.

Equities

CYCC

US23254L8019

Market Closed - Nasdaq 04:30:00 2024-04-24 pm EDT Pre-market 08:13:47 am
2.3 USD +28.49% Intraday chart for Cyclacel Pharmaceuticals, Inc. 2.335 +1.53%

Chart calendar Cyclacel Pharmaceuticals, Inc.

a28609a05142a69a84df52.VeEn49FvyAfY5iHDBJPggLtOGlAD44PqkfD1IkJwTvk.GKcKooccoHCKskmqa_uu3_AETwdostmi_ZGqSnNAPrBjoBSV6S3lVuqIUg~7990313aacfdd2772af20b09e45910f5

Upcoming events on Cyclacel Pharmaceuticals, Inc.

2024-05-07 Q1 2024 Earnings Release (Projected)
2024-05-31 06:30 pm American Society of Clinical Oncology Annual Meeting - Abstract No: 3125
2024-08-06 Q2 2024 Earnings Release (Projected)
2024-11-12 Q3 2024 Earnings Release (Projected)
2025-03-31 Q4 2024 Earnings Release (Projected)

Past events on Cyclacel Pharmaceuticals, Inc.

2024-04-09 04:30 pm American Association for Cancer Research Meeting - Abstract No: 5711 / 11
2024-04-08 12:00 pm American Association for Cancer Research Meeting - Abstract No: 2117 / 8
2024-04-07 04:30 pm American Association for Cancer Research Meeting - Abstract No: 518 / 15
2024-03-19 04:30 pm Q4 2023 Earnings Call
2024-03-19 04:05 pm Q4 2023 Earnings Release
2024-03-16 Roth Conference
2024-02-26 02:30 pm BIO CEO & Investor Conference
2024-01-08 02:00 pm Biotech Showcase
2023-12-17 Reverse Split: 1 of 15
2023-12-08 09:30 am Extraordinary Shareholders Meeting
2023-11-13 04:30 pm Q3 2023 Earnings Call
2023-11-13 04:05 pm Q3 2023 Earnings Release
2023-08-09 04:30 pm Q2 2023 Earnings Call
2023-08-09 04:05 pm Q2 2023 Earnings Release
2023-06-13 12:00 pm Annual General Meeting
2023-05-11 04:30 pm Q1 2023 Earnings Call
2023-05-11 04:05 pm Q1 2023 Earnings Release
2023-03-13 06:00 pm Roth Conference
2023-03-13 10:00 am Oppenheimer Healthcare Conference
2023-03-06 04:30 pm Q4 2022 Earnings Call

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,42
0,39
7.97%

0,00

EBITDA
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
-9,68
-9,42
-2.75%
-10,6
-10,2
-4.7%
-22,9
-23,1
0.75%
-27,7
-25,7
-7.71%
-25,5
-26,3
3.24%

-16,3

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-9,13
-8,88
-2.82%
-9,68
-9,25
-4.68%
-22,7
-23,0
1.22%
-25,9
-24,4
-6.29%
-25,6
-26,1
2.17%

-26,5

Net income
Million USD
Released
Forecast
Spread
-8,03
-7,99
-0.49%
-12,4
-8,41
-47.43%
-19,1
-20,4
6.36%
-21,4
-21,3
-0.4%
-22,8
-23,2
1.72%

-23,7

EPS
USD
Released
Forecast
Spread
-150
-153
1.96%
-51,3
-38,4
-33.42%
-32,1
-34,6
7.16%
-28,5
-26,7
-6.74%
-26,8
-20,2
-32.25%

-13,4

Announcement Date26/02/2025/02/2128/03/2206/03/2319/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,37
0,00
-
0,02
0,00
-
0,03
0,00
-

0,00


0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
-6,53
-6,71
2.62%
-6,56
-7,15
8.3%
-5,79
-6,98
17.08%
-6,47
-6,79
4.8%
-8,85
-6,94
-27.53%
-7,32
-9,28
21.1%
-5,93
-7,12
16.78%
-6,85
-5,99
-14.3%
-5,36
-6,21
13.73%

-4,54


-4,08


-3,88


-3,76

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-6,49
-6,72
3.37%
-5,25
-7,27
27.88%
-5,56
-7,07
21.4%
-6,11
-6,83
10.5%
-9,00
-6,78
-32.68%
-7,12
-9,29
23.3%
-6,03
-7,26
16.94%
-6,70
-5,82
-15.16%
-5,69
-6,21
8.31%

-6,49


-6,61


-6,72


-6,84

Net income
Million USD
Released
Forecast
Spread
-5,34
-6,65
19.68%
-4,16
-7,07
41.17%
-4,63
-5,66
18.24%
-5,15
-6,37
19.27%
-7,47
-6,54
-14.15%
-5,85
-8,42
30.43%
-5,50
-6,59
16.63%
-6,15
-5,26
-16.97%
-5,32
-5,70
6.61%

-5,99


-6,11


-6,22


-6,34

EPS
USD
Released
Forecast
Spread
-8,10
-10,3
21.17%
-6,30
-10,3
38.69%
-6,90
-8,06
14.42%
-6,30
-7,65
17.65%
-9,00
-7,24
-24.35%
-7,05
-9,95
29.15%
-6,60
-7,55
12.58%
-7,35
-5,45
-34.86%
-6,23
-5,89
-5.71%

-4,56


-3,44


-3,20


-2,59

Announcement Date28/03/2211/05/2210/08/2209/11/2206/03/2311/05/2309/08/2313/11/2319/03/24----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. CYCC Stock
  4. Calendar Cyclacel Pharmaceuticals, Inc.